版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
HypertensiveEmergencyDanielJ.McFarlaneM.D.DivisionofHospitalMedicineJanuary2011OutlineEpidemiologyDefinitionsPathophysiologyDiagnosisandRecognitionTreatmentSpecialCircumstancesEpidemiologyWhyshouldwecareabouthypertension?OneofthemostcommonchronicmedicalconcernsintheUSAffects>30%ofthepopulation>age20RiskfactorforCardiovasculardiseaseandmortalityCerebrovasculardiseaseandmortalityEndstagerenaldiseaseOtherendorgandamageDefinitionsHypertension(accordingtoJNCVII)NormalBP <120/<80Prehypertension 121-139/80-89StageIHTN 140-159/90-99StageIIHTN >160/>100(SevereHTN >180/>110)SevereHTNisnotaJNCVIIdefinedentityDefinitionsHypertensiveEmergencyAcute,rapidlyevolvingend-organdamageassociatedwithHTN(usu.DBP>120)BPshouldbecontrolledwithinhoursandrequiresadmissiontoacriticalcaresettingHypertensiveUrgencyDBP>120thatrequirescontrolinBPover24to48hoursNoendorgandamageMalignantHypertensionisnolongerusedDefinitionsEnd-OrganDamage(%ofcases)Cerebralinfarction…… 24%Hypertensiveencephalopathy……16%Intracranialhemorrhage……………4.5%Acuteaorticdissection………………2%Acutecoronarysyndrome/myocardialinfarction…12%Pulmonaryedemawithrespiratoryfailure…………22%Severeeclampsia/HELLPsyndrome………………2%Acutecongestiveheartfailure……14%Acuterenalfailure……9%PathophysiologyHypertensiveEmergencyFailureofnormalautoregulatoryfunctionLeadstoasharpincreaseinsystemicvascularresistanceEndovascularinjurywitharteriolenecrosisIschemia,plateletdepositionandreleaseofvasoactivesubstancesFurtherlossofautoregulatorymechanismExposesorganstoincreasedpressureDiagnosisandRecognitionPresentationAlwayspresentwithanewonsetsymptomTakeagoodhistoryHistoryofHTNandpreviouscontrolMedicationswithdosageandcomplianceIllicitdruguse,OTCdrugsDiagnosisandRecognitionPhysicalConfirmBPinmorethanoneextremityEnsureappropriatecuffsizePulsesinallextremitiesLungexam—lookforpulmonaryedemaCardiac—murmursorgallops,angina,EKGRenal—renalarterybruit,hematuriaNeurologic—focaldeficits,HA,alteredMSFundoscopicexam—retinopathy,hemorrhageDiagnosisandRecognitionLaboratory/RadiologicevaluationsBasicMetabolicPanel(BUN,Cr)CBCwithsmear(hemolyticanemia)Urinalysis(proteinuria,hematuria)EKGtolookforischemiaCXRtolookforpulmonaryedemaifdyspneaHeadCTforhemorrhageifHAoralteredMSMRIchestifunequalpulsesandwidemediastinumtolookforaorticdissectionTreatmentHypertensiveUrgencyNoend-organdamage—NOTemergentLookforreactiveHTNandtreatthisfirstDrugs,pain,anxiety,cocaine,withdrawalUseoralmedicationstolowerBPgraduallyover24-48hours,likely2agentsneededMaybechronic,decreaseBPslowlytoavoidhypoperfusionoforgansAvoidsublingualandIMadministrationduetounpredictableabsorptionTreatmentHypertensiveUrgencyAppropriatefollowupforasymptomaticpatientswithnoend-organdamage BPrange ActionPlan140-159/90-99 Observe,confirmBP2mos160-179/100-109 Confirm,treatwithin1mo180-209/110-119 Confirm,treatwithin1wk210+/120+ Confirm,treatnow,closef/uMedicationsOraldrugchoicesoftenbasedoncomorbidconditionsHeartfailure—TH,BB,ACEI,ARB,ALDOPostMI—BB,ACEI,ALDOHighCVDrisk—TH,BB,ACEI,CCB Diabetes—TH,BB,ACEI,ARB,CCBChronicRenalFailure—ACEI,ARBRecurrentstrokeprevention—TH,ACEIKEY:ACEI,angiotensinconvertingenzymeinhibitor;ALDO,aldosteroneantagonist;ARB,angiotensinreceptorblocker;BB,bblocker;CCB,calciumchannelblocker;TH,thiazide.TreatmentHypertensiveEmergencyActQuicklyStartIVgoaldirectedpharmacologictherapyContinuousinfusion:shortactingtitratablemedsInitiatecriticalcaremonitoringIntraorticBPmonitoringmaybenecessaryStartSLOW:LimitinitialloweringofBPto20%belowpretreatmentlevelDuetoincreasedthresholdofhypoperfusionoftheorgansfromabnormalautoregulationGoal:LowerDBPby10-15%in30-60minInitiateoraltherapyandtitrateIVmedicationsdownMedicationsIV,shortacting,titratable.ArterialVasodilatorsHydralazine,fenoldepam,nicardipine,enalaprilVenousVasodilatorsNitroglycerineMixedArterialandVenousVasodilatorsSodiumnitroprussideNegativeInotrope/ChronotropeLabetolol(alsovasodilates),EsmololAlphablockers(inc.sympatheticactivity)PhentolamineMedicationsPreferredagentsbyusageLabetolol>Esmolol>Nicardipine>Fenoldopam(espinpheochromocytoma)PreferredagentsbyendorgandamagePulmonaryEdema(systolic)—NicardipinePulmonaryEdema(diastolic)—EsmololAcuteMI—LabetololorEsmololHypertensiveEncephalopathy—LabetololAcuteAorticDissection—LabetololEclampsia—LabetololorNicardipineAcuteRenalFailure—FenoldopamSympatheticCrisis/Cocaine—VerapamilorDiltiazemSpecialCircumstancesAcuteAorticDissectionStartIVmedsSTATtolowerpulsitileloadandaorticstresstolessenthedissectionVasodilatorsalonemayreflextachycardiaUsebetablockerANDvasodilatorEsmololandNitroprussideSurgicalevaluationTypeAallgotosurgeryTypeBonlyifrupture/leak.TreatwithaggressiveBPcontrolSpecialCircumstancesStrokeNumberonecauseofpermanentdisabilityHTNisaprotectivephysiologiceffecttomaintainbloodflowtobrainOnestudyshowedbetteroutcomeifhypertensiveuponpresentationofstrokeTreatHTN“rarelyandcautiously”LowerBP10-15%infirst24hours(not>20%)HemorrhagicstrokeTreatif>200/>110,butstillwithmodestloweringofBPbecausestillworseoutcomewithlowBPSpecialCircumstancesEclampsiaVasoconstrictedandhemoconcentratedVolumeexpand,magnesiumsulfate,andaggressiveBPcontrol.DeliveryisonlydefinitivetreatmentLabetololorNicardipinearedrugsofchoice.Hydralazinewasfirstlinebutslowonsetandunpredictablesomayleadtohypotension
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 透析枸橼酸钠抗凝方法
- 高强度间歇训练
- 毕业设计结构设计
- 广告拍摄计划流程
- 腹主动脉瘤内科保守治疗方案
- 射线检测流程标准化实施要点
- 凯迪拉克的车型介绍
- 汽车过户协议书范本
- 2025-2026学年北京市东城区三年级语文上册期中考试试卷及答案
- 北师大版八年级物理上册月考考试试题及答案
- 2025年船舶建造合同协议样本
- 工业高质量数据集研究报告 2025 中国工业互联网研究院
- 2025江苏苏州市姑苏区劳动人事争议仲裁院协理员招聘5人考试参考试题及答案解析
- JJG 693-2011可燃气体检测报警器
- 酒店用品设备采购投标方案(技术方案)
- GB/T 9695.13-2009肉与肉制品钙含量测定
- GB/T 25067-2020信息技术安全技术信息安全管理体系审核和认证机构要求
- 常用钢材热处理工艺参数
- 非煤矿山建设项目管理办法
- 2023年中国中煤能源集团有限公司校园招聘笔试题库及答案解析
- 姓氏源流与文化寻根(精品·创新·实用)课件
评论
0/150
提交评论